OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
June 02, 2023
The latest on its implementation—and the implications for biopharma.
The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.
May 31, 2023
How current frameworks influence coverage decisions and pricing negotiations.
May 17, 2023
The products, cloud revenue management solution provider says, are aimed at addressing supply chain challenges.
April 24, 2023
Cost Plus Drug Co. adds J&J's Janssen medications to its offerings, increasing affordability for diabetes patients.
March 31, 2023
How various factors are affecting the amount of funds allocated to healthcare.
March 23, 2023
Pharma Commerce provides a look into a few of the conference’s highlights.
March 20, 2023
AmerisourceBergen exec explains how his experience in health policy analysis and data analytics helps him tackle patient access obstacles.
AmerisourceBergen exec dives into the shift in Medicare Part D patient requirements.